Chester County News and Community Website
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) recently announced CABA-201, a newly designed, fully human CD19 chimeric antigen receptor (CAR) containing a 4-1BB co-stimulatory domain.
Cabaletta Bio, Inc. Announces CABA-201 Read More
PENNSYLVANIA — It’s that time of year again when we start thinking about getting our flu shots. But this year, there’s another vaccination we need to consider: the COVID-19 booster. …
PA Department of Health Recommends Flu Shot and COVID-19 Booster Read More
DOWNINGTOWN, PA — Two high school seniors from the Chester County Technical College High School (TCHS) Brandywine Campus’ Allied Health program are using their passion for the medical field to …
Two TCHS Brandywine Students Are Being Published in Multiple Scientific Journals Read More
WASHINGTON, D.C. — The following is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research:
FDA Limits Use of Certain Monoclonal Antibodies to Treat COVID-19 Due to the Omicron Variant Read More
WASHINGTON, D.C. — A new CDC study published in the journal Clinical Infectious Diseases (CID) shows that flu vaccination protected children against serious flu illness even when they were infected with …
CDC Study Shows Flu Vaccination Prevents Severe Flu Illness in U.S. Children Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently approved Solensia (frunevetmab injection), the first treatment for the control of pain associated with osteoarthritis in cats and the first …
FDA Approves Novel Treatment to Control Pain in Cats with Osteoarthritis, First Monoclonal Antibody Drug for Use in Any Animal Species Read More WASHINGTON, D.C. — The U.S. Food and Drug Administration recently, conditionally approved Canalevia-CA1 (crofelemer delayed-release tablets) for the treatment of chemotherapy-induced diarrhea in dogs. This is the first treatment to …
FDA Conditionally Approves First Oral Tablet to Treat Chemotherapy-Induced Diarrhea in Dogs Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently authorized the marketing of the first laser-based device for the removal of Inferior Vena Cava (IVC) filters. The device is …
FDA Grants Marketing Authorization for Inferior Vena Cava Filter Removal Device Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued an emergency use authorization (EUA) for Merck’s molnupiravir for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults with positive …
FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults Read More
WEST READING, PA — Tower Health Medical Group now offers a mobile eye clinic for patients in the Street Medicine Program. This new service began on September 28, 2021, and …
Tower Health Medical Group Street Medicine Program Now Offers Mobile Eye Clinic Read More